antimony has been researched along with Leishmaniasis in 175 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 125 (71.43) | 18.7374 |
1990's | 11 (6.29) | 18.2507 |
2000's | 19 (10.86) | 29.6817 |
2010's | 14 (8.00) | 24.3611 |
2020's | 6 (3.43) | 2.80 |
Authors | Studies |
---|---|
Badarau, IA; Caruntu, A; Caruntu, C; Periferakis, A; Periferakis, AT; Scheau, AE; Scheau, C | 1 |
Gutierrez Guarnizo, SA; Karamyshev, AL; Karamysheva, ZN; Muskus, CE; Tikhonova, EB | 1 |
Douanne, N; Fernandez-Prada, C; Leprohon, P; Ouellette, M; Roy, G; Wagner, V | 1 |
Croft, SL; Loiseau, PM; Pomel, S | 1 |
Andrews, PC; Blair, VL; Duffin, RN; Kedzierski, L | 1 |
Bomfim, LGS; de Almeida, RP; de Jesus, AR; de Moura, TR; Dos Santos, PL; Lipscomb, MW; Magalhães, LS; Santos, CNO; Tanajura, DM | 1 |
Braillard, S; Caljon, G; Chatelain, E; Hendrickx, S; Mabille, D; Maes, L; Mowbray, CE; Van den Kerkhof, M | 1 |
Bresson, E; Fernandez-Prada, C; Leprohon, P; Ouellette, M; Plourde, M; Roy, G; Sharma, M | 1 |
Caljon, G; Cos, P; Delputte, P; Gielis, JF; Hendrickx, S; Maes, L; Van Bockstal, L; Van den Kerkhof, M | 1 |
Andrade, HF; Borborema, SE; Nascimento, Nd; Osso, JA | 1 |
SCHMIDT, H | 1 |
Diaz-Toro, Y; Fernández, OL; Gomez, MA; Muvdi, S; Ovalle, C; Rodríguez, I; Saravia, NG; Valderrama, L | 1 |
Castanys, S; Gamarro, F; Manzano, JI; Perea, A | 1 |
Bezerra, MA; Cardozo, MC; Cavalcante, DD; Santos, WN; Silva, DL | 1 |
Alvares-Saraiva, AM; Benites, NR; Bomfim, MDC; Bonamin, LV; Buchi, DF; Casarin, RCV; Correia, MSF; Dalboni, LC; de Santana, FR; Konno, FT; Lallo, MA; Laurenti, MD; Nascimento, KF; Peres, GB; Perez, EC | 1 |
Goyeneche-Patino, DA; Saravia, NG; Valderrama, L; Walker, J | 1 |
CROIZAT, P; REVOL, L | 1 |
Baiocco, P; Colotti, G; Franceschini, S; Ilari, A | 1 |
Demicheli, C; Frézard, F; Ribeiro, RR | 1 |
Kunick, C; Ryczak, J | 1 |
KIRK, R | 1 |
BRUNDRETT, JC; MAEGRAITH, B | 1 |
RAGU, J; SCHNEIDER, J | 1 |
DIDIER, R | 1 |
SANYAL, SC | 1 |
GELLHORN, A; VAN DYKE, HB | 1 |
PESSOA, SB; VILLELA, F | 1 |
CHAKRAVARTY, NK; SEN GUPTA, PC | 2 |
Ait-Oudhia, K; Garcia, D; Gazanion, E; Ouaissi, A; Oury, B; Sereno, D; Seveno, M; Vergnes, B | 1 |
SAN ANTONIO ALVAREZ, J | 1 |
HO, EA; SOONG, HY; YUAN, IC | 1 |
DASTIDAR, SK | 1 |
MURANO, G | 1 |
CHAKRAVARTY, KC | 1 |
FERNANDEZ CASTANYS, A | 1 |
BOSE, AN; GHOSH, TN | 1 |
ANDERSON, HH; MAR, J; REED, RK | 1 |
Ait-Oudhia, K; Gazanion, E; Oury, B; Sereno, D; Vergnes, B | 2 |
Chakravarty, J; Sundar, S | 1 |
Bavchvarov, BI; Campillo, M; Castanys, S; Gamarro, F; López-Martín, C; Martínez-García, M; Pérez-Victoria, JM; Torrecillas, IR | 1 |
Baker, NC; Blanco, V; Craft, N; Garcerant, D; Martinez, J; Rubiano, L | 1 |
NOGUER MORE, S | 1 |
BOSQ, PJ; KAMINSKY, A; KAPLAN, H; MAZZINI, R | 1 |
BOIX BARRIOS, J | 1 |
BHATTACHARYYA, B; DAS, AK; SANYAL, NN; SEN GUPTA, PC | 1 |
GENET, L | 1 |
FLOCH, H; SUREAU, P | 1 |
CASILE, M; SACCHARIN, H | 1 |
PFEIFER, E | 1 |
BERNARD, R; GIRAUD, P; VINCENT, P | 1 |
FLOCH, H | 1 |
CORNEJO, A | 1 |
BRAHMACHARI, PN; KAR, CC; MAITI, CR | 1 |
ARDAILLOU, R; NAJEAN, Y | 1 |
MATOS, J; VELASCO, JA | 1 |
DI CARLO, FC; PESSAT, OA; WILDE, H | 2 |
BOUDIN, G; PEPIN, B | 1 |
CARVALHO, O | 1 |
BATISTA, G; BRENER, Z; FURTADO, TA | 3 |
HOEKENGA, MT; TUCKER, HA | 1 |
ERCOLI, N | 1 |
CHATTERJI, A; MUKHERJEE, AM; SEN GUPTA, PC | 1 |
GUSEINZADE, KM | 1 |
PI FERRER, A; SALA GINABREDA, JM; WOESSNER CASAS, S | 1 |
BENABADJI, A; CHARLAS, R | 1 |
LARRIBAUD, J; MEMIN, Y; PERNOD, J | 1 |
CAHILL, KM | 2 |
KANIN, HJ; WELSH, EC | 1 |
NARVA, WM | 1 |
BARANSKI, MC; DE LACERDA, FS; GERMINIANI, H; SILVEIRADAMOTA, CC | 1 |
DEGREGORIO, G; QUATTROCCHI, G | 1 |
GIRAUD, F; ORSINI, A; RAYBAUD, C | 1 |
SCHNEIDER, J | 1 |
CACHIA, EA; FENECH, FF | 1 |
TELLA, A | 1 |
DOBRZHANSKAIA, RS | 3 |
NEAL, RA | 3 |
DEMPSEY, JJ | 1 |
OLEFFE, J; VANBREUSEGHEM, R; VANDERMEIREN, L | 1 |
YOKOKAWA, K | 1 |
CAMBI, P | 1 |
CHAKRAVARTI, RN; SEN GUPTA, PC | 1 |
BOIX BARRIOS, J; SANCHO PASQUAU, V | 1 |
LAVERDE, A | 1 |
Cunningham, ML; Fairlamb, AH; Wyllie, S | 1 |
TUCKMAN, E | 1 |
CROSCA, A | 1 |
de YTURRIAGA, E; GONZALEZ BOTELLA, S | 1 |
EAGLE, H; GERMUTH, FG; OYAMA, V | 1 |
Brochu, C; Haimeur, A; Ouellette, M | 1 |
Roscoe, M | 1 |
Chai, Y; Chow, LM; Sun, H; Wong, IL; Yan, S | 1 |
de Oliveira, FB; Demicheli, C; Dzamitika, SA; Falcão, CA; Frézard, F; Garnier-Suillerot, A; Marbeuf, C; Rossi-Bergmann, B | 1 |
de Castro Pimenta, AM; Demicheli, C; dos Santos Ferreira, C; Frézard, F | 1 |
Farnetani, F; Farnetani, I | 1 |
Soto, J; Soto, P | 1 |
Cervantes, D; Fischbach, LA; Ojha, RP | 1 |
de Moura, FJ; de Souza Furtado, R; Leal, PP; Muniz-Junqueira, MI; Veiga, JP | 1 |
BERTRAND, L; IZARN, P; JABON, M | 1 |
Fairlamb, AH; Vickers, TJ; Wyllie, S | 1 |
Steck, EA | 2 |
Fisher, BK; Schewach-Millet, M; Semah, D | 1 |
Berman, JD | 1 |
Fattah, AA; Ismail, MA; Morsy, TA | 1 |
El-Nasr, MS; Morsy, TA | 1 |
Freeman, K | 1 |
Heimgartner, E | 1 |
Hidalgo, H; Solano, E; Zeledón, R | 1 |
Armas, JA; Moreno, G; Rezzano, S; Scorza, JV | 1 |
Bassiouny, A | 1 |
Chapman, WL; Hanson, WL; Hendricks, LD | 1 |
Avila, JL; Biondo, F; Convit, J; Monzón, H | 1 |
Berman, JD; Chulay, JD; Hendricks, LD; Oster, CN | 1 |
Singh, S; Sundar, S | 1 |
Añez, N; Burguera, JL; Burguera, M; Lugo de Yarbuh, A; Petit de Peña, Y | 1 |
Barbieri, CL; Cantos, G; Gorin, PA; Iacomini, M; Travassos, LR | 1 |
Slappendel, RJ; Teske, E | 1 |
Amusategui, I; Sainz, A; Tesouro, MA | 1 |
Atienza Fernández, F; Castelló Viguer, MT; Cuesta Estellés, G; Echánove Errazti, I; Esteban Esteban, E; Ridocci Soriano, F | 1 |
Herwaldt, BL | 1 |
Shaked, P; Ulrich, N; Zilberstein, D | 1 |
Alberola, J; Arboix, M; Díez-Cascón, A; Gállego, M; González-Ensenyat, P; Portús, M; Ramos, G; Riera, C; Solano-Gallego, L; Valladares, JE | 1 |
Miekeley, N; Mortari, SR; Schubach, AO | 1 |
Carrió, J; Portús, M | 1 |
Holbrook, TW; Palczuk, NC | 1 |
Chastanet, B; Lapierre, J; Piguet, B | 1 |
Smit, AM; van der Kaay, HJ | 1 |
Alving, CR; Chapman, WL; Hanson, WL; Hendricks, LD; Steck, EA; Swartz, GM; Waits, VB | 1 |
Marsden, PD | 1 |
Long, JC | 1 |
Borgatti, MA; La Placa, M; Manson-Bahr, PE; Musumeci, S; Pampiglione, S | 1 |
Bryceson, A | 1 |
Kürkçüoğlu, N; Tandoğdu, R | 1 |
De Rivera, MV; Franke, ED; Kruger, JH; Lucas, CM; Tovar, AA; Wignall, FS | 1 |
Dorea, JG; Holzbecher, J; Merchan-Hamann, E; Ryan, DE | 1 |
Arana, BA; Arana, FE; Castillo, AL; de Mérida, AM; Navin, TR; Pozuelos, JL | 1 |
Vion, B | 1 |
Jackson, JE; Tally, JD; Tang, DB | 1 |
Aboul Anaan, AM; Essa, MH; Montasser, MF; Morsy, TA | 1 |
Marsden, PD; Sampaio, JH; Sampaio, RN | 1 |
Santrich, C; Saravia, NG; Valderrama, L; Weigle, KA | 1 |
Anciaux, ML; Bourée, P; Taugourdeau, P | 1 |
Abdel Wahab, RM; Essa, MH; Helmy, OM; Morsy, TA; Ramadan, NF | 1 |
Chong, H | 1 |
Chaniotis, BN; Christensen, HA; de Vasquez, AM; Johnson, CM | 1 |
Alfred, C; Brandicourt, O; Gentilini, M; Mazier, D; Monjour, L; Nzuzi, KK; Ploton, I; Tselentis, Y; Vouldoukis, I | 1 |
Ramírez, O | 1 |
Belazzoug, S; Neal, RA | 1 |
Barral, A; Barreto, AC; Carvalho, EM; Costa, JM; Cuba, CC; Llanos-Cuentas, EA; Magalhães, AV; Marsden, PD; Netto, EM; Rosa, AC | 1 |
Bernstein, R; Ellman, MH; Person, DA; Walton, BC | 1 |
Bray, RS | 1 |
Abdalla, RE; Ali, M; el-Hassan, AM; Wasfi, AI | 1 |
Casals, JB | 1 |
Kurban, A | 1 |
Kern, F; Pedersen, JK | 1 |
Guerra, R; Molinelli, G; Tosi, P | 1 |
Mngola, EN; Mutinga, MJ | 1 |
Abbadi, M; Addadi, K; Hamladji, MR; Tabet-Derraz, O | 1 |
Pessoa, SB; Silva, Ade A | 1 |
Girgis, NI; Khayyal, MT; Mikhail, JW | 1 |
Perschin, GN | 1 |
Bryceson, AD | 1 |
Goltz, RW; Hart, M; Livingood, CS; Totonchy, M | 1 |
Meuwissen, OJ; van der Linde, DL; van Gorp, LH | 1 |
13 review(s) available for antimony and Leishmaniasis
Article | Year |
---|---|
Availability, Toxicology and Medical Significance of Antimony.
Topics: Antimony; Humans; Leishmaniasis; Minerals; Mining | 2022 |
Chitosan Contribution to Therapeutic and Vaccinal Approaches for the Control of Leishmaniasis.
Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Betulinic Acid; Biocompatible Materials; Chitosan; Curcumin; Drug Carriers; Drug Compounding; Humans; Hydrogen-Ion Concentration; Leishmaniasis; Leishmaniasis Vaccines; Macrophages; Nanoparticles; Paromomycin; Pentacyclic Triterpenes; Polymers; Rifampin; Selenium; Thiomalates; Titanium; Triterpenes; Ursolic Acid | 2020 |
Pentavalent antimonials: new perspectives for old drugs.
Topics: Animals; Antimony; Humans; Leishmania; Leishmaniasis; Liposomes; Organometallic Compounds; Trypanocidal Agents | 2009 |
[Agents for the treatment of leishmaniasis. Antimony, and more].
Topics: Animals; Antimony; Antiprotozoal Agents; Enzyme Inhibitors; Humans; Leishmaniasis; Models, Molecular; Molecular Conformation; NADH, NADPH Oxidoreductases; Organometallic Compounds | 2009 |
Antimony toxicity.
Topics: Antimony; Heart; HIV Infections; Humans; Leishmaniasis; Occupational Exposure; Pancreatitis; Quality Control | 2010 |
Leishmania antimony resistance: what we know what we can learn from the field.
Topics: Antimony; Antiprotozoal Agents; Drug Resistance; Humans; India; Leishmania; Leishmaniasis; Treatment Failure | 2011 |
Leishmaniasis: early diagnosis is key.
Topics: Animals; Antimony; Antiprotozoal Agents; Diagnosis, Differential; Early Diagnosis; Humans; Leishmaniasis; Mouth Mucosa; Nasal Mucosa; Parasitemia; Pentamidine; Psychodidae; Time Factors; Zoonoses | 2005 |
[Current situation and future of antileishmanial therapy in Colombia].
Topics: Antimony; Antiprotozoal Agents; Colombia; Forecasting; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2006 |
The chemotherapy of protozoal infections: whither?
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Disease Models, Animal; Glycolipids; Humans; Leishmaniasis; Leishmaniasis, Visceral; Liposomes; Lysosomes; Malaria; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Primaquine; Protozoan Infections; Trypanosomiasis | 1981 |
American cutaneous leishmaniasis.
Topics: Antimony; Antimony Sodium Gluconate; Antiparasitic Agents; Antiprotozoal Agents; Belize; Central America; Diagnosis, Differential; Humans; Leishmaniasis; Meglumine; Military Medicine; Skin Diseases, Parasitic; South America; United Kingdom | 1983 |
Leishmaniasis.
Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Drug Administration Schedule; Female; HIV Infections; Humans; Leishmania; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Male | 1999 |
Oriental sore. A look at trends in and approaches to the treatment of leishmaniasis.
Topics: Allopurinol; Aminoquinolines; Antimony; Antimony Sodium Gluconate; Cryosurgery; Humans; Leishmaniasis; Leishmaniasis, Mucocutaneous; Levamisole; Liposomes; Meglumine; Meglumine Antimoniate; Metronidazole; Nifurtimox; Organometallic Compounds; Phenothiazines; Rifampin | 1986 |
Leishmaniasis in the Old World.
Topics: Africa; Anemia; Animals; Antibodies; Antimony; Carrier State; Climate; Disease Reservoirs; Erythromycin Ethylsuccinate; Humans; Immunoglobulin G; India; Insect Vectors; Leishmania; Leishmaniasis; Leishmaniasis, Visceral; Mice; Phlebotomus; Serum Albumin; Sudan | 1972 |
4 trial(s) available for antimony and Leishmaniasis
Article | Year |
---|---|
The effect of intravenous or subcutaneous administration of meglumine antimonate (Glucantime) in dogs with leishmaniasis. A randomized clinical trial.
Topics: Animals; Antimony; Antiprotozoal Agents; Disease-Free Survival; Dog Diseases; Dogs; Female; Injections, Intravenous; Injections, Subcutaneous; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Remission Induction; Treatment Outcome | 1997 |
Long term improvement in the treatment of canine leishmaniosis using an antimony liposomal formulation.
Topics: Animals; Antimony; Delayed-Action Preparations; Dog Diseases; Dogs; Leishmaniasis; Liposomes; Male | 2001 |
Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala.
Topics: Adult; Animals; Antimony; Antiprotozoal Agents; Follow-Up Studies; Guatemala; Hot Temperature; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Military Personnel; Organometallic Compounds; Radio Waves; Randomized Controlled Trials as Topic; Sorbitol | 1990 |
Failure of meglumine antimoniate to cure cutaneous lesions due to Leishmania major in Algeria.
Topics: Adolescent; Algeria; Antimony; Antiprotozoal Agents; Child; Clinical Trials as Topic; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1986 |
158 other study(ies) available for antimony and Leishmaniasis
Article | Year |
---|---|
Translational reprogramming as a driver of antimony-drug resistance in Leishmania.
Topics: Antimony; Antiprotozoal Agents; Drug Resistance; Humans; Leishmania; Leishmaniasis | 2023 |
MRPA-independent mechanisms of antimony resistance in Leishmania infantum.
Topics: Animals; Antimony; Antiprotozoal Agents; ATP-Binding Cassette Transporters; Dogs; Drug Resistance; Genes, Protozoan; Humans; Leishmania infantum; Leishmaniasis; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Mutation; Protozoan Proteins; Serine O-Acetyltransferase; Whole Genome Sequencing | 2020 |
Development of new combination anti-leishmanial complexes: Triphenyl Sb(V) mono-hydroxy mono-quinolinolates.
Topics: Animals; Antimony; Antiprotozoal Agents; Cell Line; Crystallography, X-Ray; Humans; Hydroxyquinolines; Leishmania major; Leishmaniasis; Ligands; Mice; Molecular Structure; Organometallic Compounds; Reactive Oxygen Species; X-Ray Diffraction | 2021 |
Antimony resistance associated with persistence of Leishmania (Leishmania) infantum infection in macrophages.
Topics: Antimony; Drug Resistance; Humans; Leishmania infantum; Leishmaniasis; Macrophages; Meglumine Antimoniate | 2021 |
In vitro and in vivo pharmacodynamics of three novel antileishmanial lead series.
Topics: Animals; Antimony; Antiprotozoal Agents; Boron Compounds; Cricetinae; Female; Inhibitory Concentration 50; Leishmania donovani; Leishmania infantum; Leishmaniasis; Mice; Nitroimidazoles; Parasitic Sensitivity Tests; Pyrazoles | 2018 |
High-throughput Cos-Seq screen with intracellular Leishmania infantum for the discovery of novel drug-resistance mechanisms.
Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Cosmids; CRISPR-Cas Systems; Drug Resistance; Gene Library; High-Throughput Nucleotide Sequencing; Leishmania infantum; Leishmaniasis; Life Cycle Stages; Macrophages; Phosphorylcholine | 2018 |
Impact of primary mouse macrophage cell types on Leishmania infection and in vitro drug susceptibility.
Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Cells, Cultured; Drug Resistance; Female; Interleukin-6; Leishmania infantum; Leishmaniasis; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nitric Oxide; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2018 |
Biodistribution of meglumine antimoniate in healthy and Leishmania (Leishmania) infantum chagasi-infected BALB/c mice.
Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Female; Leishmania infantum; Leishmaniasis; Meglumine; Meglumine Antimoniate; Mice, Inbred BALB C; Organometallic Compounds; Radioisotopes; Radiopharmaceuticals; Time Factors; Tissue Distribution | 2013 |
An advance in the therapeutics of pentavalent antimony: Solustibosan. (Sodium antimony gluconate).
Topics: Antimony; Antimony Sodium Gluconate; Filariasis; Humans; Leishmaniasis; Sodium | 1950 |
Miltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in Colombia.
Topics: Adolescent; Adult; Aged; Antimony; Child; Child, Preschool; Cohort Studies; Colombia; Drug Resistance; Humans; Infant; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Phosphorylcholine; Randomized Controlled Trials as Topic; Young Adult | 2014 |
The LABCG2 Transporter from the Protozoan Parasite Leishmania Is Involved in Antimony Resistance.
Topics: Antimony; Antiprotozoal Agents; ATP-Binding Cassette Transporters; Cell Membrane; Drug Resistance; Leishmania major; Leishmaniasis; Parasitic Sensitivity Tests; Protozoan Proteins | 2016 |
Multivariate optimization of a method for antimony determination by hydride generation atomic fluorescence spectrometry in hair samples of patients undergoing chemotherapy against Leishmaniasis.
Topics: Antimony; Antiprotozoal Agents; Hair; Humans; Leishmaniasis; Spectrometry, Fluorescence; Spectrophotometry, Atomic | 2016 |
High dilutions of antimony modulate cytokines production and macrophage - Leishmania (L.) amazonensis interaction in vitro.
Topics: Animals; Antimony; Leishmania; Leishmaniasis; Macrophages; Mice; Monokines; RAW 264.7 Cells | 2017 |
Antimony resistance and trypanothione in experimentally selected and clinical strains of Leishmania panamensis.
Topics: Animals; Antimony; Antiprotozoal Agents; Buthionine Sulfoximine; Drug Resistance; Glutathione; Humans; Leishmania; Leishmaniasis; Parasitic Sensitivity Tests; Spermidine | 2008 |
A case of kalaazar quickly cured by 2.168 R. P. and diamidine; diagnostic difficulties with histio-monocytic reticuloendotheliosis.
Topics: Antimony; Antiprotozoal Agents; Humans; Inorganic Chemicals; Leishmaniasis | 1948 |
Molecular basis of antimony treatment in leishmaniasis.
Topics: Amino Acid Sequence; Animals; Antimony; Binding Sites; Crystallography, X-Ray; Kinetics; Leishmania donovani; Leishmania infantum; Leishmaniasis; Models, Molecular; Molecular Sequence Data; NADH, NADPH Oxidoreductases; NADP; Oxidation-Reduction; Protein Conformation; Protein Folding; Sequence Alignment; Trypanocidal Agents; Trypanosoma cruzi | 2009 |
Observations on the use of sodium antimony gluconate (sodium stibogluconate) in the treatment of kalaazar.
Topics: Antimony; Antimony Sodium Gluconate; Humans; Leishmaniasis; Sodium | 1947 |
Sodium stibogluconate in the treatment of kalaazar; report on the treatment of eight cases and the appearance of probable drug reactions.
Topics: Antimony; Antimony Sodium Gluconate; Humans; Leishmaniasis | 1947 |
Treatment of cutaneous leishmaniasis with methylglucamine antimoniate (2.168 R. P.).
Topics: Antimony; Leishmaniasis | 1947 |
Two cases of infant kalaazar cure with N. methylglucamine antimoniate or 2.168-R. P.
Topics: Antimony; Child; Humans; Infant; Leishmaniasis | 1947 |
Stibanate (sodium antimony gluconate) with pedunculine in the treatment of kalaazar.
Topics: Antimony; Antimony Sodium Gluconate; Humans; Leishmaniasis; Sodium | 1947 |
The correlation between distribution of antimony in tissues and chemotherapeutic effect in experimental leishmaniasis.
Topics: Antimony; Leishmaniasis | 1946 |
[New observations on the treatment of cutaneous leishmaniasis by antimon-detoxin].
Topics: Antimony; Leishmaniasis; Leishmaniasis, Cutaneous | 1946 |
Sodium antimony v. gluconate in the treatment of Indian kala-azar.
Topics: Antimony; Antimony Sodium Gluconate; Asian People; Humans; Leishmaniasis; Leishmaniasis, Visceral; Sodium | 1946 |
In vitro activity of nicotinamide/antileishmanial drug combinations.
Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Cell Line; DNA Fragmentation; Drug Combinations; Drug Resistance; Flow Cytometry; Humans; Leishmania infantum; Leishmaniasis; Niacinamide; Parasitic Sensitivity Tests; Pentamidine | 2011 |
Antimony therapy in visceral leishmaniasis.
Topics: Antimony; Leishmaniasis | 1945 |
Difference in responses of Leishmania canis and Leishmania donovani toward ureastibamine.
Topics: Animals; Antimony; Canidae; Leishmania; Leishmania donovani; Leishmaniasis; Organometallic Compounds; Urea | 1945 |
A new sodium antimony gluconate for the treatment of kala-azar.
Topics: Antimony; Gluconates; Humans; Leishmaniasis; Leishmaniasis, Visceral; Sodium | 1945 |
About stibio-intolerance and stibio-resistance in the treatment of internal leishmaniasis.
Topics: Antimony; Leishmaniasis | 1945 |
The treatment of kalaazar with sodium antimony gluconate (stibatin) further observations on the treatment of 32 cases.
Topics: Antimony; Antimony Sodium Gluconate; Humans; Leishmaniasis; Sodium | 1945 |
New contributions to the treatment of infantile kala-azar by antimony hexonate in oily and concentrated solution.
Topics: Antimony; Leishmaniasis | 1945 |
The treatment of kala-azar with sodium antimony-v-gluconate; preliminary observations.
Topics: Antimony; Antimony Sodium Gluconate; Gluconates; Humans; Leishmaniasis; Leishmaniasis, Visceral; Sodium; Stomach | 1945 |
On the toxicity of some organic antimonial drugs used for the treatment of kala-azar.
Topics: Antimony; Leishmaniasis; Leishmaniasis, Visceral | 1946 |
Comparative toxicity and efficacy of urea stibamines in experimental leishmaniasis.
Topics: Antimony; Humans; Leishmaniasis; Organometallic Compounds; Urea | 1946 |
The fitness of antimony-resistant Leishmania parasites: lessons from the field.
Topics: Animals; Antimony; Antiprotozoal Agents; Drug Resistance; Humans; Leishmania; Leishmaniasis; Parasitic Sensitivity Tests | 2011 |
Sitamaquine overcomes ABC-mediated resistance to miltefosine and antimony in Leishmania.
Topics: Aminoquinolines; Antimony; Antiprotozoal Agents; ATP-Binding Cassette Transporters; Drug Resistance, Bacterial; Ketoconazole; Leishmania tropica; Leishmaniasis; Phosphorylcholine; Protein Binding | 2011 |
Possible links between sickle cell crisis and pentavalent antimony.
Topics: Anemia, Sickle Cell; Antimony; Child; Glutathione; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 2012 |
[Parenteral glucantime therapy of bouton d'orient, with esthetic results superior to intralesional therapy].
Topics: Antimony; Esthetics; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1952 |
[Aleppo boil].
Topics: Antimony; Humans; Leishmaniasis | 1952 |
[N-methylglucamine antimoniate in the treatment of visceral leishmaniasis; first cases treated in Spain].
Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spain | 1952 |
Treatment of post-kala-azar dermal leishmaniasis with methyl glucamine antimoniate.
Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Visceral | 1952 |
[Cure in a case of leishmaniasis].
Topics: Animals; Antimony; Dog Diseases; Dogs; Leishmaniasis | 1952 |
[Mucocutaneous leishmaniasis brasiliensis in French Guiana].
Topics: Antimony; French Guiana; Humans; Leishmaniasis; Leishmaniasis, Mucocutaneous | 1953 |
[Treatment of American leishmaniasis].
Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Cutaneous | 1953 |
[On the therapy of espundia].
Topics: Antimony; Arsphenamine; Humans; Leishmaniasis; Leishmaniasis, Cutaneous | 1954 |
[Note on the use of drugs with antimony base; a case of kala-azar treated with glucantime].
Topics: Antimony; Hypersensitivity; Immune System Diseases; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1954 |
[The activity of intramuscular glucantime and of intravenous anthiomaline in the treatment of sylvan American leishmaniasis].
Topics: Antimony; Furans; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1955 |
[Leishmaniasis mucocutaneous americana; our experience in its treatment with glucantime].
Topics: Antimony; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1955 |
Agranulocytosis following antimony therapy in kala-azar.
Topics: Agranulocytosis; Antimony; Humans; Leishmaniasis; Leishmaniasis, Visceral | 1955 |
[The treatment of leishmaniasis].
Topics: Amidines; Antimony; Humans; Leishmaniasis | 1955 |
[Two cases of kala-azar treated with glucantime].
Topics: Antimony; Child; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1955 |
[Autochthonous kala-azar (visceral leishmaniasis); treatment with antimonial derivatives: personal observation].
Topics: Antimony; Gluconates; Humans; Leishmaniasis; Leishmaniasis, Visceral | 1956 |
[Autochthonous kala-azar (visceral leishmaniasis); treatment with antimonial derivatives].
Topics: Antimony; Gluconates; Humans; Leishmaniasis; Leishmaniasis, Visceral | 1956 |
[Toxic nephritis during the course of antimony treatment of kala-azar].
Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Visceral; Nephritis | 1957 |
[Test treatment with N-methylglucamine antimoniate in the diagnosis of kala-azar in children].
Topics: Antimony; Child; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1958 |
[Therapeutic trails in American tegumental leishmaniasis. I. Sodium antimonyl-gluconate (triostib)].
Topics: Antimony; Gluconates; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Schistosomicides; Sodium; United States | 1959 |
[Therapeutic trials in tegumental American leishmaniasis. II. TWSb].
Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Succinates | 1959 |
[Therapeutic trials in American cutaneous leishmaniasis. III. Sodium stibogluconate].
Topics: Antimony; Antimony Sodium Gluconate; Enzyme Inhibitors; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; United States | 1959 |
Treatment of American dermal leishmaniasis with a special oral dosage form of tartar emetic.
Topics: Antimony; Antimony Potassium Tartrate; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Succinates; United States | 1959 |
Chemotherapeutic studies on cutaneous leishmaniosis.
Topics: Amebicides; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antimony; Dermatologic Agents; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous | 1961 |
Antimony dextran complex in the treatment of leishmaniasis.
Topics: Antimony; Dextrans; Humans; Leishmaniasis | 1961 |
[Treatment of cutaneous tuberculoid leishmaniasis].
Topics: Antimony; Diathermy; Electrocoagulation; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Quinacrine | 1963 |
[8 cases of kala-azar cured with glucantime].
Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1962 |
[Azotemic nephritis during antimony therapy of a case of infantile visceral leishmaniasis].
Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Visceral; Nephritis; Uremia; Urologic Diseases | 1962 |
[IMPORTANCE OF LYMPH NODE BIOPSY IN THE DIAGNOSIS OF KALA-AZAR IN THE ADULT].
Topics: Adult; Antimony; Biopsy; Blood Protein Disorders; Blood Protein Electrophoresis; Diagnosis; Humans; Leishmaniasis; Leishmaniasis, Visceral; Lymph Nodes; Prednisone; Splenomegaly | 1963 |
THE HUMAN TRYPANOSOMATIDAE. III. LEISHMANIASIS: KALA-AZAR.
Topics: Amidines; Antimony; Child; DDT; Dental Prophylaxis; Hexachlorocyclohexane; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Nutritional Physiological Phenomena; Nutritional Sciences; Pathology; Toxicology; Trypanosomatina | 1963 |
KALA-AZAR IN WISCONSIN, CASE REPORT.
Topics: Antimony; Blood Proteins; Blood Sedimentation; Complement Fixation Tests; Humans; Leishmaniasis; Leishmaniasis, Visceral; Leukocyte Count; Liver Function Tests; Spleen; Splenectomy; Wisconsin | 1963 |
CUTANEOUS LEISHMANIASIS.
Topics: Antimony; Benzenesulfonates; Biopsy; Dermatology; Humans; Injections, Intramuscular; Leishmaniasis; Leishmaniasis, Cutaneous; Organometallic Compounds | 1964 |
[ELECTROCARDIOGRAPHIC CHANGES OBSERVED IN PATIENTS SUBJECTED TO ANTIMONY THERAPY].
Topics: Antimony; Coronary Disease; Electrocardiography; Heart Block; Humans; Leishmaniasis; Pericarditis; Schistosomiasis | 1963 |
[CONTRIBUTION TO THE KNOWLEDGE OF VISCERAL LEISHMANIASIS OF THE ADULT].
Topics: Adult; Anti-Bacterial Agents; Antimony; Bone Marrow Examination; Chloramphenicol; Diagnosis; Electrocardiography; Epidemiology; Humans; Italy; Leishmaniasis; Leishmaniasis, Visceral; Protein Synthesis Inhibitors; Punctures; Sternum; Tetracycline | 1963 |
[KALA-AZAR].
Topics: Adolescent; Aging; Antimony; Antiprotozoal Agents; Biopsy; Blood Cell Count; Blood Protein Disorders; Bone Marrow Examination; Child; Diagnosis; Epidemiology; Fever; France; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Liver; Lymph Nodes; Pallor; Spleen; Splenomegaly | 1964 |
[LEISHMANIASIS AS ENCOUNTERED IN FRANCE. CLINICAL AND THERAPEUTIC ASPECTS].
Topics: Amidines; Antimony; Blood Protein Electrophoresis; Clinical Laboratory Techniques; Diagnosis; Epidemiology; France; Humans; Leishmaniasis; Leishmaniasis, Visceral | 1964 |
A REVIEW OF KALA-AZAR IN MALTA FROM 1947 TO 1962.
Topics: Anemia; Antimony; Blood Transfusion; Bone Marrow Examination; Child; Diagnosis, Differential; Dietary Proteins; Epidemiology; Humans; Insecticides; Leishmaniasis; Leishmaniasis, Visceral; Malta; Mediterranean Islands | 1964 |
CHEMOTHERAPY OF TROPICAL DISEASES.
Topics: Amebiasis; Amebicides; Anti-Bacterial Agents; Antimalarials; Antimony; Arsenicals; Chagas Disease; Chloroquine; Dysentery, Amebic; Emetine; Humans; Iodoquinol; Leishmaniasis; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Malaria; Suramin; Trypanosomiasis; Trypanosomiasis, African; United States | 1964 |
[TUBERCULOID FORM OF CUTANEOUS LEISHMANIASIA (ETIOLOGY, PATHOGENESIS, CLINICAL ASPECTS AND THERAPY)].
Topics: Administration, Cutaneous; Antimony; Leishmaniasis; Leishmaniasis, Mucocutaneous | 1964 |
[CUTANEOUS LEISHMANIASIS OF THE EYE].
Topics: Antimony; Conjunctiva; Drug Therapy; Geriatrics; Gluconates; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Ophthalmology | 1964 |
LEISHMANIASIS IN THE SUDAN REPUBLIC. XXI. INFECTION IN AMERICAN PERSONNEL.
Topics: Africa; Africa, Eastern; Antimony; Drug Therapy; Epidemiology; Humans; Leishmaniasis; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Pathology; Skin Tests; Sudan; United States | 1964 |
CHEMOTHERAPY OF CUTANEOUS LEISHMANIASIS: LEISHMANIA TROPICA INFECTIONS IN MICE.
Topics: Amidines; Animals; Antimony; Antiprotozoal Agents; Chloroquine; Chlortetracycline; Dapsone; Deoxyribonuclease I; Emetine; Hyaluronoglucosaminidase; Hydrastis; Leishmania tropica; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Mice; Pathology; Pharmacology; Primaquine; Pyrimethamine; Quinacrine; Research; Streptodornase and Streptokinase; Streptokinase; Sulfonamides; Surface-Active Agents; Toxicology | 1964 |
LEISHMANIASIS IN THE SUDAN REPUBLIC (26). ELECTROCARDIOGRAPHIC FINDINGS IN SUDANESE KALA-AZAR.
Topics: Africa; Africa, Eastern; Antimony; Black People; Electrocardiography; Humans; Leishmaniasis; Leishmaniasis, Visceral; Sudan | 1965 |
[5 CASES OF CUTANEOUS LEISHMANIASIS].
Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Quinacrine | 1964 |
[AMERICAN LEISHMANIASIS, A CASE REPORT].
Topics: Antimony; Brazil; Chloroquine; Drug Therapy; Humans; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous | 1965 |
[N-methylglucamine antimoniate (glucantime) in therapy of infantile visceral leishmaniasis; a further case of autocthonous infantile visceral leishmaniasis on the island of Elba].
Topics: Antimony; Humans; Islands; Leishmaniasis; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1955 |
Urinary excretion of antimony after administration of methyl glucamine antimoniate. preliminary observations.
Topics: Antimony; Humans; Leishmaniasis | 1950 |
[Therapy of visceral leishmaniasis with n-methyl-glucamine antimoniate].
Topics: Antimony; Leishmaniasis; Leishmaniasis, Visceral | 1951 |
[American leishmaniasis in hospitals of Bogotá Colombia].
Topics: Antimony; Colombia; Hospitals; Humans; Leishmaniasis; Leishmaniasis, Cutaneous | 1952 |
Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani.
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Cells, Cultured; Cricetinae; Disulfides; Drug Resistance; Humans; Leishmania donovani; Leishmaniasis; Mesocricetus; Oxidation-Reduction; Sulfhydryl Compounds | 2004 |
Treatment of Chinese kala-azar with sodium antimony gluconate.
Topics: Antimony; Antimony Sodium Gluconate; Asian People; Humans; Leishmaniasis; Leishmaniasis, Visceral; Sodium | 1949 |
[Hemoglobin metabolism in antimony resistant leishmaniasis in children of long standing].
Topics: Antimony; Child; Hemoglobins; Humans; Leishmaniasis | 1950 |
[Our experience in the treatment of kala-azar].
Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Visceral | 1950 |
The rate of disappearance of Leishmania donovani from the spleen of the infected golden hamster following a single injection of a pentavalent antimonial.
Topics: Animals; Antimony; Cricetinae; Humans; Leishmania donovani; Leishmaniasis; Mesocricetus; Spleen | 1950 |
The heat shock protein HSP70 and heat shock cognate protein HSC70 contribute to antimony tolerance in the protozoan parasite leishmania.
Topics: Animals; Antimony; Antimony Potassium Tartrate; Cosmids; Dose-Response Relationship, Drug; Drug Resistance; Gene Expression; HSC70 Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Leishmania; Leishmaniasis; Stress, Physiological; Transfection | 2004 |
Complexation of antimony (Sb(V)) with guanosine 5'-monophosphate and guanosine 5'-diphospho-D-mannose: formation of both mono- and bis-adducts.
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Chromatography, High Pressure Liquid; Guanosine Diphosphate Mannose; Guanosine Monophosphate; Humans; In Vitro Techniques; Kinetics; Leishmania; Leishmaniasis; Magnetic Resonance Spectroscopy; Spectrometry, Mass, Electrospray Ionization | 2005 |
Role of residual Sb(III) in meglumine antimoniate cytotoxicity and MRP1-mediated resistance.
Topics: Animals; Antimony; Antiprotozoal Agents; Cations; Cell Line; Drug Resistance, Microbial; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Multidrug Resistance-Associated Proteins; Organometallic Compounds | 2006 |
Characterization of reactions of antimoniate and meglumine antimoniate with a guanine ribonucleoside at different pH.
Topics: Animals; Antimony; Antiprotozoal Agents; Guanosine Monophosphate; Hydrogen-Ion Concentration; Leishmaniasis; Meglumine; Meglumine Antimoniate; Nuclear Magnetic Resonance, Biomolecular; Organometallic Compounds; Spectrometry, Mass, Electrospray Ionization; Thermodynamics | 2006 |
[Why was Rocco Jemma the greatest Italian paediatrician?].
Topics: Antimony; Antimony Sodium Gluconate; Child; History, 19th Century; History, 20th Century; Humans; Injections, Intravenous; Italy; Leishmaniasis; Pediatrics; Societies, Medical | 2006 |
Oral pentoxifylline and pentavalent antimony for treatment of leishmaniasis: promising but inconclusive evidence of superiority, compared with antimony monotherapy.
Topics: Administration, Oral; Antimony; Drug Therapy, Combination; Humans; Leishmaniasis; Pentoxifylline | 2007 |
Pentoxifylline prevents the meglumine antimonate-induced renal toxicity in rats, but not that induced by the inorganic antimony pentachloride.
Topics: Animals; Antimony; Antiprotozoal Agents; Chlorides; Dose-Response Relationship, Drug; Kidney Diseases; Kidney Function Tests; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentoxifylline; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2008 |
Fatal accident of N. methyl glucamine antimoniate intolerance; sero-hemorrhagic apoplexy of the brain during the treatment of an adult kalaazar.
Topics: Antimony; Antiprotozoal Agents; Brain; Cerebral Hemorrhage; Glucosamine; Humans; Intracranial Hemorrhages; Leishmaniasis | 1949 |
Roles of trypanothione S-transferase and tryparedoxin peroxidase in resistance to antimonials.
Topics: Animals; Antimony; Antiprotozoal Agents; Drug Resistance; Humans; Leishmania; Leishmaniasis; Parasitic Sensitivity Tests; Peroxidases; Protein Disulfide-Isomerases; Protozoan Proteins; Recombinant Proteins | 2008 |
Leishmaniasis recidivans treated with sodium stibogluconate.
Topics: Adult; Anti-Bacterial Agents; Antimony; Antimony Sodium Gluconate; Gluconates; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence | 1981 |
In vitro susceptibility of antimony-resistant Leishmania to alternative drugs.
Topics: Amphotericin B; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antimony; Formycins; Humans; Imidazoles; Ketoconazole; Leishmaniasis; Pentamidine; Piperazines | 1982 |
Treatment of cutaneous leishmaniasis in Saudi Arabia.
Topics: Antimony; Antiprotozoal Agents; Drug Evaluation; Female; Humans; Leishmaniasis; Male; Organometallic Compounds; Rifampin; Succimer | 1983 |
A case of oriental sore diagnosed as pseudolymphoma cutis.
Topics: Antimony; Female; Humans; Leishmania; Leishmaniasis; Middle Aged; Organometallic Compounds; Succimer | 1983 |
[Cutaneous leishmaniasis in patients returning from the tropics].
Topics: Adolescent; Adult; Aged; Antimony; Antiprotozoal Agents; Benzenesulfonates; Female; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Sulfamethoxazole; Travel; Tropical Climate | 1984 |
[Successful intralesional treatment of leishmaniasis caused by Leishmania brasiliensis panamensis using glucantime].
Topics: Adolescent; Adult; Aged; Antimony; Child; Child, Preschool; Drug Evaluation; Female; Humans; Infant; Infant, Newborn; Leishmania; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 1984 |
[Experimental chemotherapy in cutaneous leishmaniasis. III. Effect of glucantime and humatin (P&D) on Leishmania garnhami and Leishmania braziliensis in hamsters].
Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Drug Therapy, Combination; Female; Leishmania; Leishmaniasis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Sex Factors | 1984 |
Cryosurgery in cutaneous leishmaniasis.
Topics: Antimony; Cryosurgery; Humans; Leishmaniasis | 1983 |
Toxicity and efficacy of the antileishmanial drug meglumine antimoniate in the owl monkey (Aotus trivirgatus).
Topics: Animals; Antimony; Antiprotozoal Agents; Aotus trivirgatus; Cebidae; Female; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Monkey Diseases; Organometallic Compounds | 1983 |
Cutaneous leishmaniasis in mice: resistance to glucan immunotherapy, either alone or combined with chemotherapy.
Topics: Animals; Antimony; Dose-Response Relationship, Immunologic; Female; Glucans; Immunotherapy; Leishmaniasis; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred C57BL; Mononuclear Phagocyte System; Organometallic Compounds; Sorbitol | 1982 |
Susceptibility of clinically sensitive and resistant Leishmania to pentavalent antimony in vitro.
Topics: Animals; Antimony; Drug Resistance; Humans; Leishmania; Leishmaniasis; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Macrophages | 1982 |
Toxicity of pentavalent antimony.
Topics: Antimony; Humans; Kidney Tubular Necrosis, Acute; Leishmaniasis; Nervous System | 1994 |
Antimony determination in tissues and serum of hamsters infected with Leishmania garnhami and treated with meglumine antimoniate.
Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; Injections, Intralesional; Injections, Intramuscular; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; Tissue Distribution | 1994 |
Synthesis of antimony complexes of yeast mannan and mannan derivatives and their effect on Leishmania-infected macrophages.
Topics: Animals; Antimony; Antiprotozoal Agents; Carbohydrate Sequence; Cricetinae; Drug Carriers; Lectins, C-Type; Leishmania; Leishmaniasis; Macrophages; Mannans; Mannose; Mannose Receptor; Mannose-Binding Lectins; Meglumine; Meglumine Antimoniate; Mice; Molecular Sequence Data; Organometallic Compounds; Receptors, Cell Surface; Receptors, Immunologic; Saccharomyces cerevisiae | 1993 |
Effects of antimonial therapy for canine leishmaniasis on antibody titer.
Topics: Allopurinol; Animals; Antibodies, Protozoan; Antimony; Antiprotozoal Agents; Dog Diseases; Dogs; Fluorescent Antibody Technique, Indirect; Follow-Up Studies; Injections, Intramuscular; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Regression Analysis; Time Factors | 1998 |
[Torsades de pointes during treatment of leishmaniasis with meglumine antimoniate].
Topics: Aged; Antimony; Antiprotozoal Agents; Electrocardiography; Female; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Torsades de Pointes | 1999 |
Speciation of antimony(III) and antimony(V) in cell extracts by anion chromatography/inductively coupled plasma mass spectrometry.
Topics: Animals; Antimony; Cell Extracts; Chromatography, Ion Exchange; Drug Resistance; Hydrogen-Ion Concentration; Leishmania donovani; Leishmaniasis; Mass Spectrometry; Nitric Acid; Phthalic Acids | 2000 |
Monitoring of total antimony and its species by ICP-MS and on-line ion chromatography in biological samples from patients treated for leishmaniasis.
Topics: Adult; Antimony; Antiprotozoal Agents; Chromatography, Ion Exchange; Gas Chromatography-Mass Spectrometry; Hair; Humans; Leishmaniasis; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds | 2002 |
In vitro susceptibility to pentavalent antimony in Leishmania infantum strains is not modified during in vitro or in vivo passages but is modified after host treatment with meglumine antimoniate.
Topics: Animals; Antimony; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Resistance; Humans; Leishmania infantum; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests | 2002 |
Comparison of two geographic strains of Leishmania donovani by resistance of mice to superinfection.
Topics: Animals; Antimony; Cricetinae; Female; Gluconates; Leishmania; Leishmaniasis; Liver; Mice; Myanmar; Spleen; Sudan | 1975 |
[Various clinical aspects of cutaneous leishmaniasis, a disease too often unrecognized in the Paris area. Diagnostic and therapeutic problems].
Topics: Adult; Africa, Central; Algeria; Antimony; Child; Child, Preschool; Female; Humans; Leishmania; Leishmaniasis; Male; Metronidazole; Paris; Serologic Tests | 1975 |
Cutaneous leishmaniasis [proceedings].
Topics: Antimony; Antimony Sodium Gluconate; Humans; Leishmaniasis; Leishmaniasis, Mucocutaneous; Metronidazole; Pentamidine | 1977 |
Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs.
Topics: Animals; Antimony; Antimony Sodium Gluconate; Cricetinae; Disease Models, Animal; Gluconates; Leishmaniasis; Liposomes; Liver; Meglumine; Pharmaceutical Vehicles; Phospholipids; Structure-Activity Relationship; Surface Properties | 1978 |
Current concepts in parasitology. Leishmaniasis.
Topics: Antimony; Humans; Leishmaniasis; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral | 1979 |
Leishmania tropica infections.
Topics: Antimony; Humans; Leishmaniasis; Triamcinolone Acetonide | 1977 |
Effect of sodium stibogluconate and pyrimethamine on mouse infections with Leishmania mexicana.
Topics: Administration, Oral; Animals; Antimony; Gluconates; Injections, Subcutaneous; Leishmaniasis; Mice; Pyrimethamine | 1976 |
Studies in Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar.
Topics: Adolescent; Adult; Age Factors; Aged; Antibodies; Antimony; Child; Child, Preschool; Female; Humans; Infant; Intradermal Tests; Leishmania; Leishmaniasis; Leishmaniasis, Visceral; Male; Mediterranean Islands; Middle Aged; Remission, Spontaneous | 1975 |
Cutaneous leishmaniasis.
Topics: Amphotericin B; Antimony; Humans; Leishmania; Leishmaniasis; Pentamidine; Skin | 1976 |
Interferon gamma therapy for cutaneous leishmaniasis.
Topics: Animals; Antimony; Antiprotozoal Agents; Humans; Interferon-gamma; Leishmania tropica; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recombinant Proteins | 1990 |
Diffuse cutaneous leishmaniasis acquired in Peru.
Topics: Adult; Antimony; Antiprotozoal Agents; Biopsy; Female; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Peru; Skin | 1990 |
Retention of antimony in skin biopsies of leishmaniasis patients after treatment with N-methylglucamine antimoniate.
Topics: Adolescent; Adult; Aged; Antimony; Biopsy; Child; Double-Blind Method; Drug Administration Schedule; Humans; Injections, Intravenous; Leishmaniasis; Meglumine; Meglumine Antimoniate; Middle Aged; Neutron Activation Analysis; Organometallic Compounds; Random Allocation; Skin; Sorbitol | 1990 |
[Cutaneous leishmaniasis].
Topics: Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1989 |
An in vitro micromethod for drug sensitivity testing of Leishmania.
Topics: Animals; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Culture Media; Gluconates; Humans; Least-Squares Analysis; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Regression Analysis; Sorbitol; Time Factors | 1989 |
Intradermal treatment of cutaneous leishmaniasis with two antimonial drugs.
Topics: Adult; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Gluconates; Humans; Injections, Intradermal; Leishmaniasis; Male; Organometallic Compounds; Succimer; Sulfhydryl Compounds | 1988 |
Pentavalent antimonial treatment in mucosal leishmaniasis.
Topics: Antimony; Drug Administration Schedule; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Nifurtimox; Nitrofurans; Organometallic Compounds | 1985 |
Recurrences of tegumentary leishmaniasis.
Topics: Antimony; Antiprotozoal Agents; Child; Humans; Leishmaniasis; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence | 1985 |
[Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
Topics: Adolescent; Adult; Antimony; Antimony Sodium Gluconate; Child; Child, Preschool; Female; Gluconates; Humans; Infant; Leishmaniasis; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Splenectomy | 1985 |
On the treatment of cutaneous leishmaniasis in Egypt.
Topics: Adult; Antimony; Antimony Sodium Gluconate; Gluconates; Humans; Leishmaniasis; Male; Organometallic Compounds; Succimer; Sulfhydryl Compounds | 1986 |
Acquisition, development, and treatment of Panamanian cutaneous leishmaniasis: a case history.
Topics: Administration, Topical; Antimony; Antimony Potassium Tartrate; Drug Therapy, Combination; Ketoconazole; Leishmaniasis; Male; Military Personnel; Panama Canal Zone | 1988 |
[Culture systems for production of promastigote and amastigote forms of Leishmania. Application to serological diagnosis and therapeutic trials].
Topics: Animals; Antimony; Antiprotozoal Agents; Cell Line; Culture Media; Fluorescent Antibody Technique; Leishmania; Leishmaniasis; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Serologic Tests; Time Factors | 1986 |
[Autochthonous cutaneous leishmaniasis in El Salvador. Report of 5 cases].
Topics: Adolescent; Adult; Agricultural Workers' Diseases; Animals; Antimony; Child; Chloroquine; El Salvador; Female; Humans; Leishmaniasis; Male | 1986 |
Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: a report of eight cases.
Topics: Adolescent; Adult; Aged; Antimony; Antiprotozoal Agents; Brazil; Humans; Leishmaniasis; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds | 1986 |
[Treatment of cutaneous leishmaniasis of acutely necrotizing type with solusurmine].
Topics: Adolescent; Adult; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Leishmaniasis; Male; Middle Aged; Turkmenistan | 1966 |
Treatment of American cutaneous leishmaniasis with cycloguanil pamoate.
Topics: Adolescent; Adult; Antimony; Benzenesulfonates; Costs and Cost Analysis; Humans; Injections, Intramuscular; Leishmaniasis; Male; Military Medicine; Proguanil; Triazines; United States | 1968 |
The leishmaniases.
Topics: Amidines; Antimony; Carbohydrates; Heterocyclic Compounds; Heterocyclic Oxides; Humans; Leishmania; Leishmaniasis; Organometallic Compounds; Terminology as Topic | 1974 |
Cutaneous leishmaniasis in the Sudan.
Topics: Adolescent; Adult; Aged; Antimony; Female; Fluorescent Antibody Technique; Gluconates; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Leishmania; Leishmaniasis; Male; Middle Aged; Skin Tests; Sudan | 1973 |
Pharmacokinetic and toxicological studies of antimony dextran glycoside (RL-712).
Topics: Abnormalities, Drug-Induced; Animals; Antimony; Dextrans; Fetus; Glycosides; Kidney; Leishmaniasis; Liver; Mice; Myocardium; Rabbits; Rats; Spleen | 1972 |
[What did prove useful in the treatment of leishmaniasis].
Topics: Antimony; Humans; Leishmaniasis; Sorbitol | 1973 |
Leishmaniasis in the United States. A report of ten cases in military personnel.
Topics: Adolescent; Adult; Antibodies; Antimony; Humans; Injections, Intramuscular; Leishmaniasis; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Male; Military Medicine; Panama; Recurrence; United States | 1973 |
Leishmaniasis of the lid in Tuscany.
Topics: Aged; Antimony; Gluconates; Humans; Italy; Leishmaniasis; Male | 1974 |
Alternate treatment of cutaneous leishmaniasis.
Topics: Adolescent; Adult; Antimony; Hot Temperature; Humans; Infrared Rays; Leishmaniasis; Male; Skin Diseases, Parasitic; Ultraviolet Therapy | 1974 |
[Protozoa "incertae sedis" or particular forms of Leishmania?].
Topics: Adult; Amino Sugars; Anemia; Antibodies; Antimony; Antiprotozoal Agents; Bone Marrow; Female; Fever; Hepatomegaly; Humans; Immunoelectrophoresis; Leishmania; Leishmaniasis; Middle Aged; Neurologic Manifestations; Sorbitol; Splenomegaly | 1971 |
(On a test for the evaluation of the therapeutic properties of drugs in the treatment of kala-azar)
Topics: Animals; Antimony; Antiprotozoal Agents; Leishmaniasis; Mice | 1966 |
Activity of antimony dextran glycoside (RL-712) against visceral leishmaniasis in the hamster.
Topics: Animals; Antimony; Cricetinae; Glycosides; Leishmaniasis | 1969 |
[Chemotherapy of some protozoan infections: leishmaniosis, trichomoniasis, lambliasis, toxoplasmosis].
Topics: Amidines; Animals; Anti-Bacterial Agents; Antimony; Leishmaniasis; Protozoan Infections; Rats; Toxoplasmosis; Trichomonas Infections | 1969 |
Diffuse cutaneous leishmaniasis in Ethiopia. II. Treatment.
Topics: Adolescent; Amidines; Amphotericin B; Antimony; Antiprotozoal Agents; Child; Chloroquine; Female; Gluconates; Griseofulvin; Humans; Immunity; Leishmaniasis; Primaquine; Proguanil; Sulfonic Acids | 1970 |
Effect of emetine and related compounds on experimentalutaneous leishmaniasis.
Topics: Animals; Antimony; Emetine; Gluconates; Leishmaniasis; Mice | 1970 |
Late cutaneous leishmaniasis.
Topics: Adult; Amphotericin B; Antimony; Biopsy; Chloroquine; Humans; Injections, Intradermal; Leishmania; Leishmaniasis; Male; Skin Diseases, Infectious | 1969 |
[Kala-azar in the Netherlands].
Topics: Adolescent; Antimony; Humans; Leishmania; Leishmaniasis; Leishmaniasis, Visceral; Male; Netherlands | 1969 |